Nelfinavir

NEWENTRY ; Severe acute respiratory syndrome-related coronavirus







6 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34986429 Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery. 2022 Mar 1
2 35217718 Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay. 2022 Feb 25 1
3 35364308 Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19. 2022 Jun 1
4 32737681 Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach. 2021 Feb 1
5 32406687 In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease. 2020 Jun 4 1
6 33022567 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates. 2020 Dec 1